StockClub

NKTR

NKTRNektar Therapeutics$ --
Nektar Therapeutics

Nektar Therapeutics

NKTR

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
22M USD
YoY -25.3%
Operating Income
-19M USD
YoY -233.0%
Net Income
-36M USD
YoY -596.9%
EPS
-1.78$
YoY -442.3%

Revenue

$55.2M
FY2024 Q1$21.6M
$21.6M
Q1
FY2024 Q2$45.1M
$45.1M
Q2
FY2024 Q3$69.3M
$69.3M
Q3
FY2024 Q4$98.4M
$98.4M
Q4
FY2025 Q1$10.5M
$10.5M
Q1
FY2025 Q2$21.6M
$21.6M
Q2
FY2025 Q3$33.4M
$33.4M
Q3
FY2025 Q4$55.2M
$55.2M
Q4
Actual
$-43.2M (-43.9%)

Net Income

$-164.1M
FY2024 Q1$-36.8M
$-36.8M
Q1
FY2024 Q2$-89.2M
$-89.2M
Q2
FY2024 Q3$-126.2M
$-126.2M
Q3
FY2024 Q4$-119M
$-119M
Q4
FY2025 Q1$-50.9M
$-50.9M
Q1
FY2025 Q2$-92.5M
$-92.5M
Q2
FY2025 Q3$-128M
$-128M
Q3
FY2025 Q4$-164.1M
$-164.1M
Q4
Actual
$-45.1M (-37.9%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$152.9M
Est:$159.3M
FY2020MISS
$152.9M
FY2021MISS
Actual:$101.9M
Est:$111M
FY2021MISS
$101.9M
FY2022BEAT
Actual:$92.1M
Est:$91.5M
FY2022BEAT
$92.1M
FY2023MISS
Actual:$90.1M
Est:$93.2M
FY2023MISS
$90.1M
FY2024MISS
Actual:$98.4M
Est:$104.7M
FY2024MISS
$98.4M
FY2025BEAT
Actual:$55.2M
Est:$43.6M
FY2025BEAT
$55.2M

Analyst Estimates